Michael Wang, MD, highlights several notable abstracts from ASH 2025 that collectively underscore continued progress in ...

Explore the evolution of IgA nephropathy treatment, highlighting new guidelines and targeted therapies that improve patient ...

While multi-indication bispecific therapies are likely to expand in lymphoma, their use must remain driven by efficacy, with ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...

Data presented at ASH 2025 suggest earlier-line use of cilta-cel leads to better outcomes in multiple myeloma because patients have fitter immune systems and less exhausted T cells, improving CAR T ...

Early ASH 2025 data suggest sonrotoclax is a promising therapy in MCL, supporting a broader shift toward chemo-free, ...

Consolidating treatment to a single bispecific antibody for DLBCL and follicular lymphoma can improve operational efficiency ...

Explore the evolution of IgA nephropathy treatment, highlighting new guidelines and targeted therapies that improve patient outcomes.

Social determinants of health (SDOH) were found to be associated with increased risk of heart failure (HF) and ventricular arrhythmias (VA) in patients with hypertrophic cardiomyopathy (HCM), ...

Higher nighttime light exposure is associated with increased light sleep duration, with complex effects on deep sleep duration. New research reveals how outdoor nighttime light exposure subtly impacts ...

The guidelines promote whole, nutrient-rich foods and reduced added sugars and processed items to improve national health. A healthy diet includes vegetables, fruits, legumes, nuts, whole grains, and ...

Smart pill bottles may boost adherence to oral breast cancer therapies through daily reminders and tracking, though cost and ...